Target intelligence / Profile preview

Crystallin protein (misfolded form)

Molecular classification
Other
01

Overview

Misfolded lens proteins—primarily crystallins such as α-, β-, and γ-crystallin—are structural proteins in the lens that, when destabilized by mutations or post-translational modifications (oxidation, truncation, deamidation), lose their normal soluble, transparent state and aggregate to form light-scattering opacities characteristic of cataract[1][3][6]. α-crystallin also functions as a molecular chaperone, sequestering misfolded proteins; when overwhelmed or mutated, aggregation is accelerated, leading to further lens opacification and sometimes cell death[1][2][5]. The process is central to cataract pathogenesis, but "misfolded lens proteins" describes a phenotype rather than a discrete, druggable molecular entity or validated therapeutic target[3]. Thus, it is not a canonical target but rather a pathogenic state or consequence of damaged crystallin homeostasis.

Other names
Misfolded lens crystallinsAggregated crystallinMisfolded α-crystallinMisfolded β-crystallinMisfolded γ-crystallin
02

Mechanism of action

None standard; experimental strategies aim to prevent aggregation, stabilize folding, or enhance clearance

03

Biological functions

Structural component of lensChaperone activity (α-crystallin)Lens transparency
04

Disease associations

CataractAge-related lens opacification
05

Safety considerations

Irreversible aggregation in mature lens (cells do not regenerate)non-specific targeting risks affecting normal lens transparency [3][4]
06

Interacting drugs

None (no approved or direct small-molecule drugs target misfolded crystallins specifically; research ongoing) [1][3]
07

Biomarkers

None specific; lens opacity is a clinical signgenetic mutations in CRYAA, CRYAB, CRYBB1, CRYBA1, etc. may be used in research/diagnosis [1]

Beyond the preview

Go deeper on Crystallin protein (misfolded form).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crystallin protein (misfolded form).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call